Contribution: Industrial Research Assistance Program – Contributions to Firms
Vastcon Inc.
$254,375.00
Development and Validation of a Simple Blood Test for Colorectal Cancer
FY 2019-20 · 2019-11-04
Summary
Colorectal cancer (CRC) is one of the most preventable cancers with early detection, but remains the second leading cause of cancer death in Canada and the United States. Given the high impact of CRC, there is an urgent need for a more convenient, more accurate and cost-effective screening test to triage patients for more intensive procedures such as colonoscopy. This would improve patient compliance and clinical outcomes with a significant impact on population health and health care costs. The proposed project aims to clinically validate a simple blood test developed by VastCon for CRC screening. A successful project outcome will allow the company to commercialize their innovation.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Winnipeg|Winnipeg, Manitoba, Canada
Recipient Type
For-profit organization
Business Number
810234633
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-11-04 | 2019-20 | $300,000.00 |
| 2 | 2019-11-04 | 2019-20 | $295,000.00 |
| 4 | 2019-11-04 | 2019-20 | $254,375.00 |
As published
Additional Information
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 364 days. The total amended value is -40,625 dollars.
Additional Information (French)
Cet accord a été modifié 2 fois La date de fin du présent accord a été changé de 364 jours. La valeur totale des modifications est de - 40 625 dollars.
Agreement End Date
2022-03-25
Agreement Number
937606
Agreement Start Date
2019-11-04
Agreement Title
Development and Validation of a Simple Blood Test for Colorectal Cancer
Agreement Title (French)
Développement et validation d'un test sanguin simple pour le cancer colorectal
Agreement Type
Contribution
Agreement Value
$254,375.00
Amendment Date
2021-03-23
Amendment Number
4
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Colorectal cancer (CRC) is one of the most preventable cancers with early detection, but remains the second leading cause of cancer death in Canada and the United States. Given the high impact of CRC, there is an urgent need for a more convenient, more accurate and cost-effective screening test to triage patients for more intensive procedures such as colonoscopy. This would improve patient compliance and clinical outcomes with a significant impact on population health and health care costs. The proposed project aims to clinically validate a simple blood test developed by VastCon for CRC screening. A successful project outcome will allow the company to commercialize their innovation.
Description (French)
Le cancer colorectal (CCR) est l'un des cancers les plus faciles à prévenir par la détection précoce, mais il demeure la deuxième cause de décès par cancer au Canada et aux États-Unis. Compte tenu de la forte incidence du CCR, il est urgent de mettre au point un test de dépistage plus pratique, plus précis et plus rentable pour le triage des patients en vue d'interventions plus intensives comme la coloscopie. Cete mesure améliorerait la observance des patients et les résultats cliniques, ce qui aurait une incidence importante sur la santé de la population et les coûts en soins de santé. Le projet proposé vise à valider cliniquement un test sanguin simple développé par VastCon pour le dépistage du CCR. Un projet fructueux permettra à l'entreprise de commercialiser son innovation.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Winnipeg South
Federal Riding (French)
Winnipeg-Sud
Federal Riding Number
46013
NAICS Code
33911
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
810234633
Recipient City
Winnipeg|Winnipeg
Recipient Country
CA
Recipient Legal Name
Vastcon Inc.
Recipient Postal Code
R3Y 0A2
Recipient Province or Territory
MB
Recipient Type
F
Reference Number
172-2019-2020-Q3-937606
